Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

NCT02227108 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated prior to a planned interim analysis based on lack of required efficacy in the first 32 participants enrolled.

Conditions

Interventions

Sponsor

MedImmune LLC